Advanced Neuromodulation Systems
Country not established
Advanced Neuromodulation Systems is a medical device manufacturer, with 90 devices listed in FDA GUDID, FDA 510(k) and EUDAMED (FDA Class III, II and I) and 10 FDA recalls as of 12 Nov 2026.
- Devices
- 90
- FDA recalls
- 10
Registry facts
- Registries
- FDA GUDID 63
- FDA 510(k) 27
- EUDAMED 18
- Device classes
- FDA Class III 58
- FDA Class II 30
- FDA Class I 2
- FDA recalls
At a glance
Market reach
- United States
- FDA recalls
What Advanced Neuromodulation Systems makes
Advanced Neuromodulation Systems manufactures implantable and external devices for neuromodulation therapy, including spinal cord and peripheral nerve stimulation leads (e.g., Lamitrode®, Octrode®, Quattrode®), deep brain stimulation systems (e.g., NeuroSphere™), and reusable pin-indexed adaptors (e.g., Penta™). The company also produces multiple active implantable device programmers (e.g., SJM™, Proclaim™) and noninvasive battery chargers for these systems. These products are designed for chronic pain management and neurological conditions.
The company’s devices are classified under FDA regulations as Class II and Class III, with submissions recorded in the FDA’s 510(k) and Unique Device Identifier (UDI) databases.
Catalogue
Search and filter all 90 devicesShowing 1-50 of 90
FDA recalls
FDA recall records list 10 recalls initiated by Advanced Neuromodulation Systems, the earliest on 2006-12-22 and the most recent on 2012-09-04. By recorded status: 10 terminated. The reasons filed fall into these groups: software or firmware, electrical or power and manufacturing or quality process. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.
2012
- 4 Sep 2012 Z-0025-2013 Class II Terminated Eon Mini IPGs manufactured in April 2012 could potentially exhibit a sudden, brief surge in stimulation that would be felt by the patient as uncomfortable or painful. SJMs routine testing, monitoring, and analysis of manufacturing processes identified three lots of Eon Mini IPGs that the internal battery has the potential to come into contact with the internal microcontroller board.
- 28 Mar 2012 Z-0894-2013 Class II Terminated Unintended Fluid ingress into the device header has been shown.
2011
- 19 Dec 2011 Z-1983-2012 Class II Terminated The firm has received 112 complaints of the Eon Mini IPGs that lost the ability to communicate or recharge due to a workmanship issue resulting in loss of pain relief and subsequent explant. The firm has determined the cause of these reports to be related to process variances in the positioning of the internal battery and printed circuit board, causing a short, and therefore, prematurely depletin
Full distribution text
- 19 Dec 2011 Z-2280-2012 Class II Terminated As of 11/30/2011, St. Jude Medical has received 110 patient complaints of warmth or heating at the implantable pulse generators (IPGs) implant site during charging for the Eon IPG and 116 reports of similar symptoms for the Eon Mini IPG, respectively.
Full distribution text
- 19 Dec 2011 Z-2281-2012 Class II Terminated As of 11/30/2011, St. Jude Medical has received 110 patient complaints of warmth or heating at the implantable pulse generators (IPGs) implant site during charging for the Eon IPG and 116 reports of similar symptoms for the Eon Mini IPG, respectively.
Full distribution text
- 24 May 2011 Z-2607-2011 Unclassified (pre-2012) Terminated Defective battery was identified as cause for reports of inability to communicate or recharge the product.
Full distribution text
- 19 Dec 2011 Z-1983-2012 Class II Terminated The firm has received 112 complaints of the Eon Mini IPGs that lost the ability to communicate or recharge due to a workmanship issue resulting in loss of pain relief and subsequent explant. The firm has determined the cause of these reports to be related to process variances in the positioning of the internal battery and printed circuit board, causing a short, and therefore, prematurely depletin
2010
- 23 Apr 2010 Z-1599-2010 Unclassified (pre-2012) Terminated Due to a missed inspection step during manufacturing, a small number of devices may experience a gradual or sudden loss of charging capability.
- 22 Feb 2010 Z-1425-2010 Unclassified (pre-2012) Terminated Directions For Use of product incorrectly stated lead compatibility information.
Full distribution text
2009
- 2 Jun 2009 Z-3091-2011 Unclassified (pre-2012) Terminated Product programmed with unapproved software was distributed.
2006
- 22 Dec 2006 Z-0170-2010 Unclassified (pre-2012) Terminated Product's external charging system on occasion was failing to communicate with the Implantable Pulse Generator preventing re-charging of the pain relief system.
Frequently asked questions
How many devices does Advanced Neuromodulation Systems have in the registry?
The registry currently lists 90 devices for Advanced Neuromodulation Systems. Devices recorded under merged duplicate company entries are counted once.
Which registries list Advanced Neuromodulation Systems's devices?
Among its 50 most recently registered devices, Advanced Neuromodulation Systems has devices listed in EUDAMED (14 devices) and FDA GUDID (50 devices). A device can be listed in more than one registry, so these counts overlap.
What risk classes do Advanced Neuromodulation Systems's devices fall under?
Among its 50 most recently registered devices, the classes recorded for Advanced Neuromodulation Systems's devices are Class I, Class II and Class III. Each device page shows its own class and authorisation.
Are there FDA recall records for Advanced Neuromodulation Systems?
FDA recall records list 10 recalls initiated by Advanced Neuromodulation Systems, the most recent initiated on 4 Sep 2012. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.
What are the newest devices from Advanced Neuromodulation Systems in the registry?
The most recently registered devices listed for Advanced Neuromodulation Systems include MN13650, 1210, Infinity™ 6884 and Proclaim™ 3884.